Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease Maitreyi Raman, Iftikhar Ahmed, Patrick.

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Saurabh Dawra, Vishal Sharma, Usha Dutta

Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D

Shou–Jiang Tang, Feriyl Bhaijee

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease Kathleen E. Corey, Naga Chalasani Clinical.

Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient Severin Daum, Christoph Loddenkemper,

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study Harry Wu, Geoffrey C. Nguyen Clinical.

Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies Kally Cheung, Samuel S. Lee, Maitreyi.

Rebekah S. Wieland, Richard S. Zubarik, Maryam J. Zenali

Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome Megan Rossi, Raphael Aggio,

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD

Todd H. Baron, Patrick S. Kamath, Robert D. McBane

Talya Salz, Robert S. Sandler Clinical Gastroenterology and Hepatology

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Abstracts from Around the World

Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease Sahil Mittal, Hashem.

Jessica L. Mellinger, Michael L. Volk

Patrick B. Allen, Paul J. Kettle, Inder Mainie

Activity-Based Costing and Management in a Hospital-Based GI Unit

Michael Charlton Clinical Gastroenterology and Hepatology

Alan J. Wigg, Rosemary McCormick, Rachel Wundke, Richard J. Woodman

Endoscopic Therapy for Barrett's Esophagus

Amie L. Harvey, Tommy Yen, Anand Kunda

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Michel I. Kafrouni, Robert A. Anders, Sumita Verma

Dysphagia Caused by Extrinsic Esophageal Compression From Mediastinal Lymphadenopathy in Patients With Sarcoidosis Faisal Inayat, Qulsoom Hussain, Khurram.

Joanna Gibson, Jill Lacy, Ellen Matloff, Marie Robert

Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva

Abnormal Liver Tests and Fatty Liver on Ultrasound

Gastroenterology in a New Era of Accountability: Part 2

Nonalcoholic Fatty Liver Disease in Latinos

New Models of Gastroenterology Practice

Rajasekhara R. Mummadi, Krishna S

Endoscopic Ultrasound–Guided Cholecystoduodenostomy for Acute Cholecystitis in a Patient With Thrombocytopenia and End-Stage Liver Disease Awaiting Transplantation

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

David H. Bruining, William J. Sandborn

Najat Mourra, Nikias Colignon Clinical Gastroenterology and Hepatology

Peter Bytzer Clinical Gastroenterology and Hepatology

Cholelithiasis in a Patient With History of Cholecystectomy

AGA technical review on nonalcoholic fatty liver disease

A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed? Andrew D. Rhim, Michael.

Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly Kathleen Jacobs, Sharon.

Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease Veeral Ajmera, MD, MAS, Rohit Loomba,

Issue Highlights Clinical Gastroenterology and Hepatology

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Issue Highlights Clinical Gastroenterology and Hepatology

Fasiha Kanwal, Jennifer R

Autoimmune Liver Disease Associated With Celiac Disease in Childhood: A Multicenter Study Silvia Caprai, Pietro Vajro, Alessandro Ventura, Marco Sciveres,

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Patrick Yachimski, William P. Puricelli, Norman S. Nishioka

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Black and White Liver Clinical Gastroenterology and Hepatology

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu

Rintaro Hashimoto, Akimichi Chonan

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease Maitreyi Raman, Iftikhar Ahmed, Patrick M. Gillevet, Chris S. Probert, Norman M. Ratcliffe, Steve Smith, Rosemary Greenwood, Masoumeh Sikaroodi, Victor Lam, Pam Crotty, Jennifer Bailey, Robert P. Myers, Kevin P. Rioux Clinical Gastroenterology and Hepatology Volume 11, Issue 7, Pages 868-875.e3 (July 2013) DOI: 10.1016/j.cgh.2013.02.015 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Fecal microbiome of obese NAFLD and healthy-weight control subjects. MTPS data were used to calculate the relative abundance of various bacterial taxa. The labels indicate family and genus. Clinical Gastroenterology and Hepatology 2013 11, 868-875.e3DOI: (10.1016/j.cgh.2013.02.015) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Relative proportions of dominant taxa at genus level in obese NAFLD patients and healthy-weight controls. Clinical Gastroenterology and Hepatology 2013 11, 868-875.e3DOI: (10.1016/j.cgh.2013.02.015) Copyright © 2013 AGA Institute Terms and Conditions